Obesity
Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.
Highlights of the month
- Scientific Publications
Clinical Paper Summary: Bacus et al, 2024. Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
This retrospective review evaluates real world clinical experience of concomitant use of meal replacement products and GLP-1 RAs in Australia and South Africa. The results illustrate that this combination for weight management is feasible in real-life and may offer potential advantages for weight management.
